Biotechnology & Life Sciences Global On demand · 24-48h

Global Next-Generation Sequencing Library Preparation Market Strategic Research Report

Global Next-Generation Sequencing Library Preparation Market…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Next-Generation Sequencing Library Preparation Market
$2.8B2025
11.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: DNA Library Preparation Kits, RNA Library Preparation Kits, Whole Genome Sequencing Library Prep Kits, Targeted Sequencing Library Prep Kits, Single-Cell Library Preparation Kits

By Application: Oncology & Cancer Genomics, Reproductive Health & Prenatal Testing, Infectious Disease & Pathogen Surveillance, Agricultural & Environmental Genomics, Drug Discovery & Pharmacogenomics

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Illumina, Inc., Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Pacific Biosciences, Oxford Nanopore Technologies, MGI Tech (BGI Genomics), New England Biolabs, Takara Bio Inc., Twist Bioscience

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Market size 2025
$2.8B
Billion USD
Forecast CAGR
11.2%
2025-2032
Forecast 2032
$5.9B
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

The global next-generation sequencing (NGS) library preparation market occupies a critical position within the broader genomics and molecular diagnostics ecosystem. Library preparation—the process of converting biological samples into sequencing-ready DNA or RNA fragments through steps such as fragmentation, adapter ligation, and amplification—represents one of the most reagent-intensive and technically demanding phases of the NGS workflow. Valued at approximately USD 2.8 billion in 2024, the market is closely intertwined with accelerating adoption of NGS platforms across oncology diagnostics, reproductive health, infectious disease surveillance, and agricultural genomics. As sequencing instruments become progressively more accessible and throughput-efficient, demand for high-quality, reproducible library preparation kits and automated workstations has followed a consistent upward trajectory, underpinning a commercially significant and innovation-driven sector.

Market snapshot

Global Next-Generation Sequencing Library Preparation Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 11.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.8B
2025
Forecast
$5.9B
2032
CAGR
11.2%
2025–2032
区域
5
global
Key companies
Illumina, Inc.Thermo Fisher ScientificQIAGEN N.V.Agilent TechnologiesPacific BiosciencesOxford Nanopore TechnologiesMGI Tech (BGI Genomics)New England Biolabs
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
DNA Library Preparation KitsRNA Library Preparation KitsWhole Genome Sequencing Library Prep KitsTargeted Sequencing Library Prep KitsSingle-Cell Library Preparation Kits
By Application
Oncology & Cancer GenomicsReproductive Health & Prenatal TestingInfectious Disease & Pathogen SurveillanceAgricultural & Environmental GenomicsDrug Discovery & Pharmacogenomics

Table of contents

Click a chapter to expand
01Executive Summary
  • 1.1 Market Synopsis
  • 1.2 Key Findings
  • 1.3 Strategic Recommendations
02Industry Overview & Forecast
  • 2.1 Market Definition & Scope
  • 2.2 Market Value Forecast, 2025-2032 (Value)
  • 2.3 CAGR Analysis & Confidence Intervals
  • 2.4 Historical Market Review, 2019-2024
  • 2.5 Scenario Analysis (Base, Bull, Bear Cases)
03Market Segmentation by Type
  • 3.1 Market by Type Overview
  • 3.2 DNA Library Preparation Kits (Value)
  • 3.3 RNA Library Preparation Kits (Value)
  • 3.4 Whole Genome Sequencing Library Prep Kits (Value)
  • 3.5 Targeted Sequencing Library Prep Kits (Value)
  • 3.6 Single-Cell Library Preparation Kits (Value)
04Market Segmentation by Application
  • 4.1 Market by Application Overview
  • 4.2 Oncology & Cancer Genomics (Value)
  • 4.3 Reproductive Health & Prenatal Testing (Value)
  • 4.4 Infectious Disease & Pathogen Surveillance (Value)
  • 4.5 Agricultural & Environmental Genomics (Value)
  • 4.6 Drug Discovery & Pharmacogenomics (Value)
05Regional Market Forecast
  • 5.1 Regional Revenue Share & CAGR (2024 vs 2032)
  • 5.2 Asia Pacific (Value)
  • 5.3 North America (Value)
  • 5.4 Europe (Value)
  • 5.5 Middle East & Africa
  • 5.6 Latin America
06Country-Level Market Forecast
  • 6.1 Top Countries Overview
  • 6.2 United States
  • 6.3 China
  • 6.4 Germany
  • 6.5 United Kingdom
  • 6.6 Japan
  • 6.7 India
07Growth Drivers & Inhibitors
  • 7.1 Expanding Clinical Adoption of Comprehensive Genomic Profiling in Oncology
  • 7.2 Rising Demand for Non-Invasive Prenatal Testing Driving cfDNA Library Prep Volumes
  • 7.3 Infectious Disease Surveillance Programs Accelerating Metagenomic Sequencing Library Workflows
  • 7.4 Market Restraints & Challenges
  • 7.5 Opportunities & White-Space Analysis
08Key Company Profiles
  • 8.1 Illumina, Inc. — Revenue, Strategy, Key Products
  • 8.2 Thermo Fisher Scientific Inc. — Revenue, Strategy, Key Products
  • 8.3 QIAGEN N.V. — Revenue, Strategy, Key Products
  • 8.4 Agilent Technologies, Inc. — Revenue, Strategy, Key Products
  • 8.5 Pacific Biosciences of California, Inc. — Revenue, Strategy, Key Products
  • 8.6 Oxford Nanopore Technologies plc — Revenue, Strategy, Key Products
  • 8.7 MGI Tech Co., Ltd. (BGI Genomics) — Revenue, Strategy, Key Products
  • 8.8 New England Biolabs (NEB) — Revenue, Strategy, Key Products
  • 8.9 Takara Bio Inc. — Revenue, Strategy, Key Products
  • 8.10 Twist Bioscience Corporation — Revenue, Strategy, Key Products
09Competitive Landscape
  • 9.1 Market Concentration & Competitive Intensity
  • 9.2 Market Share Analysis (2024)
  • 9.3 Competitive Positioning Matrix
  • 9.4 Recent Developments: M&A, Partnerships & Product Launches (2023-2025)
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitute Products
  • 10.5 Competitive Rivalry Intensity
11PESTLE Analysis
  • 11.1 Political Factors
  • 11.2 Economic Factors
  • 11.3 Social & Demographic Factors
  • 11.4 Technological Factors
  • 11.5 Legal & Regulatory Factors
  • 11.6 Environmental Factors
12SWOT Analysis
  • 12.1 Market-Level Strengths
  • 12.2 Market-Level Weaknesses
  • 12.3 Strategic Opportunities
  • 12.4 External Threats
13Future Trends & Outlook
  • 13.1 Automation and Microfluidic Integration Reshaping High-Throughput Library Preparation
  • 13.2 Ligation-Free and PCR-Free Library Prep Chemistries Reducing Bias and Improving Coverage Uniformity
  • 13.3 Long-Read Compatible Library Prep Protocols Gaining Adoption in Clinical and Research Settings
  • 13.4 Long-Term Market Outlook (2033-2035)
  • 13.5 Investment & M&A Activity Outlook

Frequently asked questions

What is the size of the NGS library preparation market?
The global NGS library preparation market was valued at approximately USD 2.8 billion in 2024 and is projected to reach USD 6.5 billion by 2032, driven by expanded clinical sequencing adoption across oncology, reproductive health, and infectious disease applications.
What is the CAGR of the NGS library preparation market?
The NGS library preparation market is forecast to grow at a compound annual growth rate (CAGR) of approximately 11.2% over the forecast period from 2025 to 2032.
What is driving growth in the NGS library preparation market?
Three principal forces are propelling market expansion. First, the accelerating clinical integration of comprehensive genomic profiling (CGP) in oncology—now embedded in national cancer treatment guidelines across the US, EU, and Japan—is generating sustained, high-volume demand for tumor-tissue and liquid biopsy library preparation kits. Second, expanding non-invasive prenatal testing (NIPT) programs, particularly in high-birth-rate markets such as China and India, are requiring cell-free DNA library workflows at scale. Third, COVID-19-era investments in national pathogen surveillance infrastructure have persisted and broadened into routine metagenomic and whole-genome sequencing programs, requiring standardised library preparation reagents at public health laboratories worldwide.
Who are the leading companies in the NGS library preparation market?
The market is led by Illumina, Inc., which commands the largest revenue share through its tightly integrated sequencing platform and library prep kit portfolio; Thermo Fisher Scientific, whose Ion Torrent and Oncomine product lines address clinical oncology workflows; QIAGEN, with its QIAseq targeted panel kits; Agilent Technologies, known for its SureSelect hybrid capture systems; and MGI Tech (BGI Genomics), which is gaining traction in Asian and emerging markets with competitively priced sequencing ecosystems. New England Biolabs and Takara Bio are significant suppliers of enzymatic reagents underpinning library preparation across research settings globally.
Which region dominates the NGS library preparation market?
North America held the largest revenue share in 2024, accounting for approximately 42% of global market value, attributable to the concentration of academic medical centres and clinical laboratories, high reimbursement rates for genomic diagnostics, and the headquarters presence of leading platform vendors including Illumina and Thermo Fisher Scientific. Asia Pacific is the fastest-growing region, led by China's large-scale genomic medicine initiatives and India's expanding diagnostics infrastructure.
What segments are covered in this report?
The report segments the NGS library preparation market by product type (DNA library prep kits, RNA library prep kits, whole genome sequencing kits, targeted sequencing kits, and single-cell library prep kits) and by application (oncology and cancer genomics, reproductive health and prenatal testing, infectious disease and pathogen surveillance, agricultural and environmental genomics, and drug discovery and pharmacogenomics). Regional and country-level coverage is also provided.
What is the forecast period covered in this report?
This report covers the forecast period from 2025 to 2032, with 2024 as the base year. Historical data is included for the period 2019 to 2024 to provide directional context for trend analysis.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.